Linagliptin

• Post Date:

  Oct 13,2013

• Expiry Date:

  Oct 13,2014

• Detailed Description:

  Cas No. :668270-12-0 Linagliptin is an Inhibitors of dipeptidyl peptidase 4, it is a member of the “Gliptin” class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.
  Linagliptin was FDA approved in 2011.
  

• CAS Registry Number:

  668270-12-0

• Synonyms:

  ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;

• Molecular Formula:

  C₂₅H₂₈N₈O₂

• Molecular Weight:

  472.5422

• Molecular Structure:

  

• Company:

  Stereokem     [ United States ]        

• Contact:

  Sundar Venkataraman

• Tel:

  +1-415-290-0331

• Fax:

• Email:

  Sundar@stereokem.com